Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.32%
SPX
-0.35%
IXIC
-0.29%
FTSE
+0.23%
N225
-0.65%
AXJO
+1.13%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
826.40M
Dividend Yield
0.00%
P/E Ratio
-17.16
EPS
-0.55
Revenue
-
Avg. Volume
899.35K

Recently from Cashu

publisher logo
Cashu

Anavex Life Sciences: Pioneering Innovative Alzheimer’s Therapies with ANAVEX2-73

2 days ago
publisher logo
Cashu

Anavex Life Sciences: Adapting to Biopharmaceutical and Digital Asset Market Dynamics

4 days ago
publisher logo
Cashu

Anavex Life Sciences Innovates with Ethereum Treasury Strategy for Asset Management

6 days ago

About

What does AVXL do?
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
Sector
💻 Health Care
IPO
CEO
Employees
42
Headquarters
New York, USA
Website
http://www.anavex.com
Stocks
Health Care
avxl
Anavex Life Sciences
NASDAQ: AVXL
-0.16 (-1.65%)
9.52
USD
At close at Aug 21, 19:11 UTC
Summary
News
Signals
Benchmarks
Financials